{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:44:40Z","timestamp":1782657880080,"version":"3.54.5"},"reference-count":20,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hazardous drugs preparation is a high-risk process requiring strict control of aseptic conditions to ensure product sterility and to protect healthcare workers. Isolators and laminar airflow cabinets are widely used in hospital pharmacies for the preparation of hazardous drugs. Structured assessments of process-related risks associated with routine handling practices remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to apply Failure Mode and Effects Analysis (FMEA) to identify and prioritize high-risk handling steps in hazardous drugs preparation workflows using isolators and to evaluate risk profiles associated with laminar airflow cabinets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An observational FMEA-based risk assessment was conducted in a hospital pharmacy during routine hazardous drugs preparation. Six critical handling steps were evaluated: glove installation, surface cleaning, material transfer, documentation, waste removal, and glove removal. For isolator-based preparation, 100 routine preparations were directly observed to quantify failure frequencies and to assign occurrence scores. For laminar airflow cabinets, failure modes and occurrence levels were evaluated using observational insights combined with structured expert consensus. Severity and detection scores were assigned by an interdisciplinary expert panel. Risk Priority Numbers (RPNs) were calculated to prioritize critical failure modes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FMEA identified surface cleaning, material transfer, and glove handling as the most critical steps in hazardous drugs preparation workflows. In isolator-based preparation, the highest initial RPNs were observed for surface cleaning (RPN\u2009=\u2009240), material transfer (RPN\u2009=\u2009210), and glove installation (RPN\u2009=\u2009144). Risk assessment highlighted different underlying drivers of failure across workflows. In isolators, elevated risks were mainly associated with handling complexity and limited detectability of failures within a closed system. In laminar airflow cabinets, risks were primarily related to open-system exposure and greater dependance on operator technique and environmental control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FMEA proved to be a practical tool for systematically identifying and prioritizing risks in hazardous drugs preparation workflows. The analysis highlighted critical handling steps requiring targeted risk mitigation strategies and demonstrated the importance of workflow design, operator training, and adherence to standard operating procedures. The proposed FMEA-based approach provides a transferable framework to support continuous quality improvement and enhance safety in oncology pharmacy practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261463212","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:18:47Z","timestamp":1782389927000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Failure mode and effects analysis of hazardous drugs preparation workflows using isolators with contextual evaluation of laminar airflow cabinets in hospital pharmacy"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8889-7607","authenticated-orcid":false,"given":"Seham","family":"El Deeb","sequence":"first","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cherif Chefchaouni","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Toughrai","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of visceral surgery, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamelia","family":"Amazian","sequence":"additional","affiliation":[{"name":"ISPITS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreddine","family":"Moukafih","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soufiane","family":"El Merrakchi","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimazahra","family":"Bandadi","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Hafidi","sequence":"additional","affiliation":[{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeslam","family":"El Kartouti","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Bennani","sequence":"additional","affiliation":[{"name":"Pharmacy and Dentistry of Fez University Sidi Mohamed Ben Abdellah"},{"name":"Department of Central Pharmacy, Hassan II University Hospital of Fez, Fez, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050529"},{"key":"e_1_3_2_3_2","unstructured":"Controlling Occupational Exposure to Hazardous Drugs (Occupational Safety and Health Administration guidance) https:\/\/www.osha.gov\/hazardous-drugs\/controlling-occex."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab179"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192315428"},{"key":"e_1_3_2_6_2","unstructured":"United States Pharmacopeia (USP). General Chapters <797> Pharmaceutical Compounding \u2013 Sterile Preparations Revision Bulletin Official. May 1 2020."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.61092\/iaea.40dy-lc77"},{"key":"e_1_3_2_8_2","first-page":"575","article-title":"Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries\u2014Angolan experience","volume":"9","author":"Concei\u00e7\u00e3o AV","year":"2015","unstructured":"Concei\u00e7\u00e3o AV, Bernardo D, Lopes LV. Oncology pharmacy units: a safety policy for handling hazardous drugs and related waste in low- and middle-income African countries\u2014Angolan experience. ecancermedicalscience 2015; 9: 575.","journal-title":"ecancermedicalscience"},{"key":"e_1_3_2_9_2","unstructured":"Crauste-Manciet S. Improving safety in aseptic compounding. Hospital Pharmacy Europe https:\/\/hospitalpharmacyeurope.com\/news\/improving-safety-in-aseptic-compounding\/ (2002)."},{"key":"e_1_3_2_10_2","unstructured":"Hazardous Drugs - Occupational Safety and Health Administration eTool on Preparation & Handling https:\/\/www.osha.gov\/etools\/hospitals\/pharmacy\/preparation-handling-of-hazardous-drugs."},{"key":"e_1_3_2_11_2","unstructured":"Institute for Safe Medication Practices. Guidelines for Safe Preparation of Compounded Sterile Preparations_revised 2016."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.2146\/sp140001"},{"key":"e_1_3_2_13_2","unstructured":"ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology 2022."},{"key":"e_1_3_2_14_2","unstructured":"Sterile Compounding Cleanrooms: ISO Class 5 PECs and Buffers. 2025."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1460458219895434"},{"key":"e_1_3_2_16_2","article-title":"Improving the safety of chemotherapy process by a risks management tool: chemotherapy compounding in Oncology Center in Oujda (Morocco)","volume":"2","author":"Ouasrhir A","year":"2019","unstructured":"Ouasrhir A, Bourhaleb Z, Rahhali R, et al. Improving the safety of chemotherapy process by a risks management tool: chemotherapy compounding in Oncology Center in Oujda (Morocco). Eur J Oncol Pharm 2019; 2: e19.","journal-title":"Eur J Oncol Pharm"},{"key":"e_1_3_2_17_2","unstructured":"Negative Pressure Isolators for hazardous drug compounding by Ottobix Jun 24 2025. AGMM TECH."},{"key":"e_1_3_2_18_2","unstructured":"Jamie C Ann A Matthew M. Draft ASHP Guidelines on Compounding Sterile Preparations. Approved by the ASHP Board of Directors. 2025. Developed through the ASHP Section of Inpatient Practitioners Section Advisory Group on Compounding Practice."},{"key":"e_1_3_2_19_2","first-page":"447","article-title":"Primary engineering controls in pharmaceutical compounding, part 1: unidirectional-airflow workstations, compounding aseptic isolators, and compounding aseptic containment isolators","volume":"23","author":"Mulder K","year":"2019","unstructured":"Mulder K. Primary engineering controls in pharmaceutical compounding, part 1: unidirectional-airflow workstations, compounding aseptic isolators, and compounding aseptic containment isolators. Int J Pharm Compd 2019; 23: 447\u2013452. PMID: 31751940.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_2_20_2","unstructured":"Improving the safe handling and administration of chemotherapy in cancer treatment centers. ChemoSafe. Literature and Standards Review Version 2.4 October 16 2019."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051429"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261463212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261463212","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261463212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T13:56:02Z","timestamp":1782654962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261463212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":20,"alternative-id":["10.1177\/10781552261463212"],"URL":"https:\/\/doi.org\/10.1177\/10781552261463212","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"10781552261463212"}}